Covid-19 Impact on Global Rapid Diagnostic Testing for Influenza Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Digital Rapid Influenza Diagnostic Test
  • 1.4.3 Conventional Rapid Influenza Diagnostic Test
• 1.5 Covid-19 Implications on Market by Application
  • 1.5.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2020 VS 2026
  • 1.5.2 Point-of-care Testing
  • 1.5.3 Hospitals
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Rapid Diagnostic Testing for Influenza Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Rapid Diagnostic Testing for Influenza Industry
    • 1.6.1.1 Rapid Diagnostic Testing for Influenza Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Rapid Diagnostic Testing for Influenza Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Rapid Diagnostic Testing for Influenza Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Covid-19 Implications on Global Rapid Diagnostic Testing for Influenza Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Rapid Diagnostic Testing for Influenza Growth Trends by Regions
  • 2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Share by Regions (2015-2020)
  • 2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Rapid Diagnostic Testing for Influenza Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Rapid Diagnostic Testing for Influenza Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Market Size
  • 3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2015-2020)
  • 3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio
  • 3.2.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2019
• 3.3 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served
• 3.4 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service
• 3.5 Date of Enter into Rapid Diagnostic Testing for Influenza Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2015-2020)
• 4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)
• 5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 6.2 Rapid Diagnostic Testing for Influenza Key Players in North America (2019-2020)
• 6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 7.2 Rapid Diagnostic Testing for Influenza Key Players in Europe (2019-2020)
• 7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

8 China

• 8.1 China Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 8.2 Rapid Diagnostic Testing for Influenza Key Players in China (2019-2020)
• 8.3 China Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 8.4 China Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 9.2 Rapid Diagnostic Testing for Influenza Key Players in Japan (2019-2020)
• 9.3 Japan Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 9.4 Japan Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 10.2 Rapid Diagnostic Testing for Influenza Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 10.4 Southeast Asia Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

11 India

• 11.1 India Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 11.2 Rapid Diagnostic Testing for Influenza Key Players in India (2019-2020)
• 11.3 India Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 11.4 India Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Rapid Diagnostic Testing for Influenza Market Size (2015-2020)
• 12.2 Rapid Diagnostic Testing for Influenza Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Rapid Diagnostic Testing for Influenza Market Size by Type (2015-2020)
• 12.4 Central & South America Rapid Diagnostic Testing for Influenza Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Abbot
  • 13.1.1 Abbot Company Details
  • 13.1.2 Abbot Business Overview and Its Total Revenue
  • 13.1.3 Abbot Rapid Diagnostic Testing for Influenza Introduction
  • 13.1.4 Abbot Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020))
  • 13.1.5 Abbot Recent Development
• 13.2 BD
  • 13.2.1 BD Company Details
  • 13.2.2 BD Business Overview and Its Total Revenue
  • 13.2.3 BD Rapid Diagnostic Testing for Influenza Introduction
  • 13.2.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.2.5 BD Recent Development
• 13.3 Quidel
  • 13.3.1 Quidel Company Details
  • 13.3.2 Quidel Business Overview and Its Total Revenue
  • 13.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction
  • 13.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.3.5 Quidel Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview and Its Total Revenue
  • 13.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction
  • 13.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 Thermo Fisher Scientific
  • 13.5.1 Thermo Fisher Scientific Company Details
  • 13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction
  • 13.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.5.5 Thermo Fisher Scientific Recent Development
• 13.6 Meridian Bioscience
  • 13.6.1 Meridian Bioscience Company Details
  • 13.6.2 Meridian Bioscience Business Overview and Its Total Revenue
  • 13.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction
  • 13.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.6.5 Meridian Bioscience Recent Development
• 13.7 Analytik Jena
  • 13.7.1 Analytik Jena Company Details
  • 13.7.2 Analytik Jena Business Overview and Its Total Revenue
  • 13.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction
  • 13.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.7.5 Analytik Jena Recent Development
• 13.8 Princeton BioMeditech Corporation
  • 13.8.1 Princeton BioMeditech Corporation Company Details
  • 13.8.2 Princeton BioMeditech Corporation Business Overview and Its Total Revenue
  • 13.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction
  • 13.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.8.5 Princeton BioMeditech Corporation Recent Development
• 13.9 BioMerieux
  • 13.9.1 BioMerieux Company Details
  • 13.9.2 BioMerieux Business Overview and Its Total Revenue
  • 13.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction
  • 13.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.9.5 BioMerieux Recent Development
• 13.10 Sekisui Diagnostics
  • 13.10.1 Sekisui Diagnostics Company Details
  • 13.10.2 Sekisui Diagnostics Business Overview and Its Total Revenue
  • 13.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction
  • 13.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 13.10.5 Sekisui Diagnostics Recent Development
• 13.11 Response Biomedical
  • 10.11.1 Response Biomedical Company Details
  • 10.11.2 Response Biomedical Business Overview and Its Total Revenue
  • 10.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction
  • 10.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 10.11.5 Response Biomedical Recent Development
• 13.12 SA Scientific
  • 10.12.1 SA Scientific Company Details
  • 10.12.2 SA Scientific Business Overview and Its Total Revenue
  • 10.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction
  • 10.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2015-2020)
  • 10.12.5 SA Scientific Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer